Catalyst Wire Dossier Catalyst Wire Dossier

VIOKACE

PANCRELIPASE · Aimmune Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for VIOKACE, covering 2012-03-01 to 2024-02-28. Get the full timeline:

Most recent: FDA Approved: VIOKACE — Supplemental Application (Aimmune Therapeutics, Inc.)

See pricing